Chagas Disease Model to Support Antiviral and Antiparasitic Drug Discovery

0
93

Chagas disease is endemic in many parts of Latin America, particularly affecting impoverished rural populations. It is estimated that approximately 6 to 7 million people in the region are infected with the protozoan parasite T. cruzi. The disease has also become a global public health issue, with hundreds of thousands of cases among immigrant populations, primarily in the United States and Europe. Currently, there is no vaccine available for Chagas disease. Due to the immunological complexity and chronic nature of the infection, progress in this area is uncertain.

T. cruzi is an obligate intracellular parasite with an extremely broad range of mammalian hosts and can infect most nucleated cells. In humans, the initial acute phase of the disease lasts four to six weeks, during which significant parasitaemia occurs and most tissues and organs become infected. However, symptoms are typically mild and non-specific, manifesting as short-term fever and muscle pain, and most people are unaware that they have been infected. In some cases, the disease can be more severe, particularly in children, where death may result from myocarditis or encephalopathy.

Despite being discovered over a century ago, only two drugs are currently available to treat the disease, and the results of the first clinical trial in 40 years were disappointing. There is an urgent need to develop new drugs to treat Chagas disease. This requires us to gain a deeper understanding of the parasite's infection process, as well as standardizing the animal models used for Chagas disease drug discovery and development. These measures will improve the comparability of the generated data and enhance the predictability of test hypotheses and models designed for translation to human diseases.

Creative Diagnostics believes that animal models are invaluable for studying human diseases as hundreds of pathogens affect both humans and animals. Using laboratory animals in biomedical research is key to developing new methods of prevention and treatment for infectious and non-infectious diseases. Creative Diagnostics' experienced team of professionals can provide standardized in vivo predictive models for Chagas disease, supporting drug discovery and therapeutic efficacy studies that require development and validation.

Creative Diagnostics' process for developing Chagas disease models includes developing animal models, antiparasitic treatment and clinical evaluation, including the maximum tolerated dose (MTD), parasitaemia and mortality, as well as mycological evaluation, including microscopy and histopathology. The company's strengths lie in its standardized animal and parasite strains, analytical tools and treatment regimens.

For more detailed technical specifications or to submit an inquiry regarding Chagas Disease Model customization, please visit https://antiviral.creative-diagnostics.com/chagas-disease-model.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.

Căutare
Categorii
Citeste mai mult
Alte
Thermal Insulating Tapes Market to Reach USD 1.31 Billion by 2034 at 2.9% CAGR
Global Thermal Insulating Tapes Market is gaining attention across construction, automotive,...
By Harshada Patil 2026-11-12 13:17:41 0 256
Jocuri
Monster Hunter Outlanders Shop Guide: Best Buys & Top-Up Tips
Monster Hunter Outlanders has a surprisingly deep shop system. Between the main menu shop,...
By TOPUPlive Official 2026-11-20 04:00:10 0 60
Alte
Call Girl In Chanakyapuri: Companionship For Refined Social Plans
Chanakyapuri is known for its diplomatic establishments, upscale hotels, elegant restaurants, and...
By Pooja Mehta 2026-11-16 11:11:45 0 162
Alte
Car Window Laminated Glass Market to Reach USD 6.10 Billion by 2034 at 5.6% CAGR
Global Car Window Laminated Glass Market is gaining attention across automotive safety, vehicle...
By Harshada Patil 2026-10-23 07:01:35 0 587
Alte
Electronic Grade Boron Trifluoride Market to Reach USD 498.7 Million by 2032 at 6.7% CAGR
Global Electronic Grade Boron Trifluoride Market is gaining attention across semiconductor...
By Harshada Patil 2026-10-29 13:05:00 0 274
Join JoyLife.in | Earn Money Online with Friends & Fun https://joylife.in